Yüklüyor......
Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy
The detection of rare mutational targets in plasma (liquid biopsy) has emerged as a promising tool for the assessment of patients with cancer. We determined the presence of cell-free DNA containing the BRAFV600E mutations (cfBRAFV600E) in plasma samples from 57 patients with papillary thyroid cancer...
Kaydedildi:
| Yayımlandı: | J Clin Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7464493/ https://ncbi.nlm.nih.gov/pubmed/32748840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9082481 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|